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ABSTRACT 
 
      L-Arginine (Arg or R) is a non-toxigenic, metabolically versatile and conditionally essential amino acid. Single-pot synthesis of Arg 
modified magnetic nanoparticles (RMNPs) was achieved using magnetite [Fe3O4] nanoparticles (MNPs) and binary function of Arg as a 
functional group and an alkali precipitator. This modification is supposed to offer several advantages to the MNPs from a bio-application 
viewpoint, including improved stabilization effect, bio-safety, biocompatibility and surface functionalization. Here, the influence of 
RMNPs in the structure and function of the model protein hen egg white lysozyme (HEWL) (EC 3.2.1.1) is reported. After synthesis of 
RMNPs, vibrating sample magnetometry (VSM), X-Ray Diffraction (XRD), Fourier Transform Infrared (FT-IR), Zetasizer, Transmission 
Electron Microscopy (TEM), and Scanning Electron Microscopy (SEM) were used to characterize the nanoparticles. The impact of RMNPs 
was investigated on lysozyme structure and activity during storage and in the processes of denaturation and refolding by dilution or dialysis 
using fluorescence, circular dichroism (CD) and UV-Vis spectroscopies. RMNPs revealed structural ordering or disordering effects on 
lysozyme in a RMNP:HEWL ratio dependent manner. Accordingly, a concentration ratio of threshold (CRT) was determined at 0.296. At 
ratios lower than the CRT the protein gained more ordered structure with increased helicity. Inversely, HEWL was increasingly unfolded 
and helicity was decreased at ratios higher than the CRT, rendering the protein more disordered after interaction with RMNPs. At 
RMNPs:HEWL concentration ratios above and even below the CRT, 6 M urea had a further disordering effect. Nevertheless, significant 
improvements were observed in the refolding of the protein due to dilution or dialysis, by courtesy of the RMNPs. The presented data helps 
to expand the thriving applications of RMNPs in biotechnology and biomedicine. 
 
Abbreviation: Nanoparticles: NPs; L-Arginine: Arg or R; Magnetic [Fe3O4] nanoparticles: MNPs; L-Arginine modified magnetic 
[Fe3O4@Arg] nanoparticles: RMNPs; Hen egg white lysozyme: HEWL; Concentration Ratio of Threshold: CRT; Micrococcus 
lysodeikticus: M. luteus   
 
Keywords: L-Arginine modified magnetic nanoparticle (RMNP), Hen egg white lysozyme (HEWL), Stability, Denaturation, Refolding, 
Concentration ratio of threshold (CRT) 
 
INTRODUCTION 
 
      Magnetic    nanoparticles  (MNPs)  and   Arg    modified  
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magnetic nanoparticles (RMNPs) as aminated MNPs have 
widespread applications in areas such as laboratory 
diagnostics [1], cell sorting [2], DNA sequencing [3], 
Detecting minimal traces of DNA [4], medical drug 
targeting    [5]   and   cardiovascular  disease  [6]   therapies. 
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Biological entities of a commensurate size ranging from 
cells to macromolecules can be targeted by MNPs [7]. They 
can be used to label said entities following surface 
functionalization using the appropriate bioligands [8]. 
Various modification methods have been developed to 
produce biocompatible MNPs for magnetic resonance 
imaging [9], immunoassays [10], immobilization of 
proteins, peptides or enzymes [11], and drug or gene 
delivery [12]. The superparamagnetic behavior of MNPs as 
well as being non-toxic, non-cytotoxic and non-
immunogenic, are some of the many attractive features of 
MNPs, making them an ideal candidate for many 
applications since they can be controlled and manipulated 
by an external magnetic field gradient. The impressive 
developments in nano-biotechnology have facilitated the 
adjustment and customization of their composition, size, 
surface functionalization and magnetic properties [7,13,14]. 
      MNPs can be functionalized with different organic or 
inorganic coating agents, including surfactants, polymers, 
silica, or carbon. Addition of these functional groups to 
MNPs provides a chance for engineering the surface 
properties regarding several targeted applications [13,14]. 
Coating MNPs with amino acids, for example, L-Arginine 
(Arg or R), is a resourceful strategy for developing a new 
generation of MNPs [15] which are more biocompatible and 
eco-friendly. This also helps to protect MNPs against 
agglomeration and allows them to play a role as antibody 
connectors [16], catalysts [17], drug loaders, stability 
modifiers [15] and to directly interact with proteins/peptides 
through the side chains of amino acid residues and peptide 
bonds.  
      Positively charged guanidinium groups (pKa, 12.48) 
along with three aliphatic methylene groups in Arg make it 
the most basic amino acid [18] and an alkali precipitator 
with the highest isoelectric point (pI, 10.76) [19]. In general, 
Arg modified magnetic nanoparticles [Fe3O4@Arg] or 
RMNPs are produced by direct and simple bonding upon 
Arg attachment to the surface of the MNPs through                
α-COOH groups [14,17]. In this way, guanidinium groups 
are added as a functional group to the surface of RMNPs. A 
common strategy for driving protein refolding or 
suppression of aggregation is the addition of small 
molecules known as kosmotropic co-solvents [20]. Both 
kosmotropic  [21]  and  chaotropic  effects  [22]  have  been   
 
 
reported for free Arg. Moreover, we have recently reported 
the dual concentration-dependent effect of MNPs on a well-
characterized glycoprotein, hen egg white lysozyme 
(HEWL) (EC 3.2.1.1) [23,24], a single subunit model 
protein consisting of 129 amino acid residues (with a 
molecular mass of 14.3 kDa) [25]. Nevertheless, the 
possible ambivalent effect of RMNPs on the urea-induced 
unfolding and refolding of HEWL structure and function 
which is an important issue has not been reported and the 
study of the interaction between RMNPs and HEWL in 
various fields helps to describe the interactions between bio-
macromolecules and RMNPs.  
      Therefore, in this study, we report the concentration-
dependent effects of RMNPs on ordering (structure making 
effect) or disordering (structure breaking effect) HEWL 
structure as a model protein. It was found that higher 
efficiency in biological processes can be achieved by a low 
density of RMNPs. 
 
MATERIALS AND METHODS 
 
Materials 
      HEWL from hen egg white (HEWL) (EC 3.2.1.17,    
MW: 14.5kDa), FeCl2.4H2O (99%), FeCl3.6H2O (99%), 
9,10-phenanthrenequinone and ammonium hydroxide        
(25 wt% NH3 in water) were obtained from Sigma-Aldrich. 
Arginine hydrochloride (Arg) and all organic solvents were 
from Merck (Darmstadt, Germany). Dried bacterial cell wall 
as the substrate from Gram-positive Micrococcus 
lysodeikticus (M. luteus) was prepared according to Surekha 
et al. [26].  
 
Synthesis and Characterization RMNPs 
      RMNPs were synthesized by dissolving Iron(III) 
chloride hexahydrate (FeCl3.6H2O) and Iron(II) chloride 
tetrahydrate (FeCl2.4H2O) at 2:1 molar ratio. Then, 1 mM 
Arg, as a precipitator, was added, under a nitrogen 
atmosphere while being vigorously stirred. After 1 h, 
synthesis was completed by adding 7 ml ammonium 
hydroxide (25 wt% NH3 in water) according to the 
coprecipitation method in the presence of Arg [14]. The 
product was washed with deionized water and ethanol six 
times to remove residual Arg and solvent. Finally, a magnet 
was used to separate RMNPs from the suspension, then,  the  
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black sediments of the RMNPs were dried at 40 °C. After 
completion of the synthesis, the RMNPs were characterized 
using various analytical techniques. Confirmation of the 
attachment of Arg on MNPs was achieved by a quick and 
simple method using 9-10-phenanthrenequinone [27]. The 
amount of Arg capped on RMNPs synthesis products was 
determined to be 1.62 µg (0.0093 µmol) per mg of RMNPs 
using a colorimetric method [28].  
      After synthesis of RMNPs, they were characterized 
using various analytical methods as follows. X-ray 
diffraction (XRD) was performed using a Rigaku-Dmax 
2500 diffractometer, with Cu Kα radiation (λ = 1.5406 nm) 
and 2θº from 5 to 90° in which the rate of warming-up was 
adjusted at 0.02° min-1. The Fourier-transform infrared         
(FT-IR) spectra were obtained using a Bruker VERTEX 70 
model. The RMNPs were directly monitored by scanning 
electron microscopy (SEM) with a CamScan MV2300, with 
20000 accelerating voltage for the electrons and 
magnification of 40000. The saturation magnetization (Ms) 
of RMNPs was measured by applying vibrating sample 
magnetometry (VSM) in a vibrating sample magnetometer 
(VSM) (Meghnatis Daghigh Kavir Co.; Kashan Kavir; Iran) 
at room temperature. The zeta potential (ζ mV) of RMNPs 
was determined in phosphate-buffered saline (PBS,         
100 mM, pH = 7.4) using the dynamic light scattering 
(DLS) instrument from Malvern ZS-Nano series. 
 
Enzyme Treatment by RMNPs 
      Phosphate-buffered saline (PBS, 100 mM, pH = 7.4) 
was used to prepare the HEWL (lyophilized powder, EC 
3.2.1.1; Sigma-Aldrich) stock solution and concentrations 
were adjusted using absorbance at 280 nm extinction 
coefficient [29]. In order to study the effect of RMNP on 
HEWL at three representative RMNP:HEWL ratios (0, 
0.025-1.250), appropriate amounts of RMNPs were added 
after ultrasonication at a power of 28 kHz for 10 min            
to 0.2 mg ml-1 protein without or with urea treatment. The 
mixtures were incubated for 1 hour at 25 °C with shaking at 
300 rpm to maintain homogeneity.  
 
Effect of RMNPs on Urea-induced Unfolding and 
Refolding of HEWL 
      In order to study the effect of RMNPs on urea-       
induced   HEWL  unfolding   three   representative  ratios of  
 
 
RMNP:HEWL as 0, 0.025 and 1.25, in the absence (-Urea) 
or presence (+Urea) of 6 M urea were investigated. 
Accordingly, three samples of 0.2 mg ml-1 HEWL were 
prepared in the absence (as control) or presence of RMNPs 
at 0.005 mg ml-1 and 0.250 mg ml-1, in the absence or 
presence of 6 M urea.  
      In continue, the effect of RMNPs on the efficiency of 
dilution and dialysis strategies on refolding of HEWL 
treated by 6 M urea were explored. The efficiency of 
dilution strategy on refolding of urea denatured/dissolved 
protein was investigated in three RMNP:HEWL ratios as 0, 
0.025 and 1.25 after performing 30 fold dilution using PBS, 
100 mM, pH = 7.4 [30]. Also, the effect of RMNPs (at 
RMNP:HEWL ratio of 0.025) on the refolding of urea 
denatured/dissolved HEWL was explored using dialysis 
strategy. Dialysis was performed against PBS (100 mM,        
pH 7.4) under continuous stirring for 24 h at 4 °C in dialysis 
tubes (6-8 kDa cut-off) [31]. In brief, dialysis of urea treated 
HEWL samples in the absence or presence of RMNPs were 
carried out and results were compared against two control 
samples as “-Urea, -Dialysis” and “+Urea, -Dialysis”.  
 
HEWL Assay 
     For the enzyme assay dried bacterial cell wall from the 
Gram-positive bacterium, M. luteus was prepared [32] and 
used as a substrate in 100 mM potassium phosphate pH 7.4 
at 25 °C using a UV-Vis spectrophotometer [Jenway 6500 
series] [33,34]. Briefly, after addition of 40 μl HEWL at          
0.2 mg ml-1 to 1 ml of M. luteus, the lysis of M. luteus cell 
wall was monitored by measuring the decrease in 
absorbance at 450 nm.  
 
Spectroscopic Analysis 
      Tryptophan fluorescence emission spectra of HEWL as 
control and samples with different concentrations of 
RMNPs were recorded using a spectrofluorimeter (BioTek, 
Synergy™ H4 Hybrid microplate reader) in a 96-well quartz 
plate at room temperature. The fluorescence spectrum of 
HEWL at 0.2 mg ml-1 was obtained in the wavelength range 
of 300-400 nm after excitation at 290 nm at 25 °C. In order 
to obtain the protein spectra in the presence of RMNPs, the 
suspensions were shaken for 1 h at 200 rpm under ambient 
conditions.  
      The helicity of the treated  HEWL  at  0.2 mg ml-1  in the 
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absence or presence of RMNPs at two representative 
concentrations of 0.005 and 0.250 mg ml-1 was also studied 
using the AVIV circular dichroism spectrometer Model 215, 
with and without urea (6 M) treatment followed by dialysis. 
The results were analyzed using CDNN deconvolution 
software by mean residual ellipticity (MRE) in                 
deg cm2 dmol-1. Our reported data are the mean of three 
measurements for each test. 
 
RESULTS AND DISCUSSION 
 
      Although the Arg as a kosmotropic agent is used in 
various protein recovery/refolding protocols [35], the 
modulation of this application for Arg at the surface of 
MNPs is the subject of debate. The characterization of 
synthesized nanoparticles (NPs) including MNPs and 
RMNPs was performed using X-ray diffraction (XRD), 
Fourier-transform infrared (FT-IR), vibrating sample 
magnetometry (VSM), scanning electron microscopy (SEM) 
and finally, the surface zeta potential of the particles was 
estimated using a Zeta-sizer (Fig. 1).  
      The Fourier-transform infrared (FT-IR) spectra provided 
a direct proof for the synthesis of a Fe3O4 core that was 
successfully functionalized by Arg. The FT-IR spectra 
measured the RMNPs’ bonds between different ingredients 
in the mid and near IR regions [14] in the range of 500- 
4000 cm-1, as can be seen in figure 1a. The bonds of Fe-O at 
about 520-580 cm-1 represent the formation of magnetite 
The absorption band at 2950 cm-1 is assigned to the (OH) 
stretching mode and overlaps with the C-H and N-H 
stretching vibration peaks and the weak absorption band 
observed at 1606 cm-1 is due to the bending vibration of 
absorbed water [36] which indicates the presence of water 
molecules linked to RMNPs. Stretching vibrations seen at 
~1600 cm-1 to ~1650 cm-1 are because of the C=O and C-O 
bonds and the bonds of NH2 and OH at around 2800-         
3300 cm-1 indicate that the Arg has completely modified the 
surface of the RMNPs [14,37]. According to the XRD 
analysis data, and the diffraction pattern of the RMNPs 
according to Bragg’s reflections the representative peaks 
were observed in (2 2 0), (3 1 1), (4 0 0), (4 2 2), (5 1 1),          
(4 4 0), (6 2 0), and (5 3 3) planes of the cubic phase of 
Fe3O4 (Fig. 1b), in agreement with the JCPDS card No. 19-
629  [38].  Figure 1c  shows  scanning  electron  microscopy 
 
 
(SEM) micrograph of RMNPs and its relative distribution 
sizes. According to this figure, the morphology of the 
RMNPs is clearly spherical with the average particle size of 
32.14 nm. The saturation magnetization (Ms) of RMNPs by 
applying vibrating sample magnetometry (VSM) was 
estimated to be 69.9 emu g-1 at 25°C (Fig. 1d). RMNPs 
present super-paramagnetic behavior due to being smaller 
than the critical size and they have no coercivity and 
remanence [39,40]. According to Fig. 1e, the biological 
applications of RMNPs are most profoundly impacted by 
their surface chemistry. Since the surface charge of the 
RMNPs is thought to be influenced by electrostatic 
interactions, the zeta potential (ζ mV) of RMNPs was 
determined in phosphate-buffered saline (PBS) 100 mM,    
pH = 7.4. The average zeta potential value of RMNPs is        
-34.3 mV. This measurement exhibits a large negative 
charge that can attract positively charged targets in the 
water shell that surrounds the protein molecules.  
      The effect of RMNPs on HEWL structure and activity in 
the absence or presence of urea was explored. Intrinsic 
protein fluorescence is due to aromatic amino acids, mainly 
tryptophan, which can be selectively measured by excitation 
at 280 nm [41]. Changes in emission spectra of tryptophan 
are due to the protein conformational transitions, subunit 
association, ligand binding or denaturation, which affect the 
local environment. 
      Figure 2 reveals the cumulated functions of 
RMNP:HEWL including changes in emission spectra of 
tryptophan intrinsic fluorescence, secondary structure 
alteration, and percent of remaining activity to investigate 
the effect of RMNPs on protein structure and function. The 
intrinsic fluorescence emission of HEWL is mainly due to 
Trp 62 and Trp 108 residues which makes it a useful model 
to study protein conformational changes [42]. The resulting 
spectra indicated that the environment in the vicinity of the 
tryptophan residues of the HEWL molecules was changed 
during the binding and decreased in a polar hydrophilic 
environment [43]. The fluorescence emission peaks resulted 
as a function of RMNP:HEWL ratios, using 0.2 mg ml-1 
HEWL as a model protein to study the effect of RMNPs 
concentration on HEWL conformational structure (Fig. 2a). 
RMNPs change the protein hydration pattern, resulting in 
increasing or decreasing Trp emission after excitation due to 
the protein folding or unfolding, respectively,  depending on  
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the molar ratios of RMNP:HEWL. The aforementioned 
RMNP-induced HEWL structural change brings about 
increasing or decreasing of the quantum yield of protein 
fluorescence emission with an inflection point at the 
concentration ratio of threshold (CRT) of 0.296 as depicted 
in Fig. 2a. Therefore, RMNPs represent two opposing 
effects including structure-making (or kosmotropic-like) 
and structure-breaking (or chaotropic-like) effects at lower 
and higher ratios than the CRT, respectively. A large body 
of results for various samples shows that low concentration 
of RMNPs acts as stabilizing agents (kosmotropic co-
solvents) through improving protein hydration, increasing 
protein stability and consequently maintaining biological 
activity of macromolecules [44]. To explain the effect of 
high concentrations of RMNPs on the stability of HEWL, it 
is anticipated that a vast number of RMNPs are not covered  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
by protein corona, negatively affecting protein stability and 
structure, and acting as chaotropic agents.  
      The effect of RMNP:HEWL ratios of 0.025 and 1.25 on 
HEWL helicity in the absence or presence of urea have been 
presented (Fig. 2b). Accordingly, using CD analysis as a 
quite sensitive method to study the secondary structure of 
HEWL, the protein α-helicity is affected by the RMNPs 
content of the solvent system. In accordance with 
fluorescence results in the absence of urea (-Urea), the 
helicity is increased at the RMNP:HEWL ratio of         
0.025 (< CRT) displaying even higher helicity than the 
control sample as depicted in Fig. 2b. However, when using 
lower or higher ratios (0.025 and 1.25, respectively) of 
RMNP:HEWL (< CRT or > CRT, respectively) in the 
presence of 6 M urea (+Urea), the helicity was              
severely diminished. Thus,  low  concentrations  of  RMNPs          
 
Fig. 1. (a) FT-IR spectra of MNPs, Arg and RMNPs, (b) X-ray diffraction, (c) SEM image and distribution size with particle  
            analysis using ImageJ (inset to Fig.), (d) VSM graph and (e) Zeta potential (DLS) of RMNPs. 
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(0.005 mg ml-1) lead to HEWL denaturation even more than 
the control sample (Control, +Urea). Moreover, the 
enzymatic activity of HEWL in the absence of urea rose 
sharply at RMNP:HEWL ratios of 0.025 (< CRT) and 
decreased minimally at RMNP:HEWL ratios of                    
1.25 (> CRT) (Fig. 2c). As with helicity, despite using 
lower or higher ratios of RMNP: HEWL (< CRT or > CRT, 
respectively) in the presence of 6 M urea (+Urea), the 
protein activity is decreased significantly, which is in good 
accordance with structural observations. It can thus be 
deducted that, additives act to reduce the denaturing effect 
of the denaturant chiefly by altering the balance between 
preclusion of additives, which results in enhanced hydration 
of the protein [45]. Correspondingly, pertaining to HEWL, 
it is anticipated that the addition of RMNPs shifts the 
equilibrium between the preferential binding of urea and 
preferential exclusion of NPs, leading to a reduction in the 
hydration of the protein and aiding the  destabilizing  action 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of the denaturant. Several models have explained the 
mechanism of action of denaturants (such as urea) for 
destabilizing proteins by migrating into the interior of the 
protein and forming hydrogen bonds to atoms in the 
backbone or decreasing the solvent polarity and dielectric 
constant [46]. 
      In continuance, the effect of RMNPs on the functional 
stability of HEWL was assessed (Fig. 3). The remaining 
activity of HEWL as a model protein was monitored for 64 
h in the absence of RMNPs (as control) and presence of 
RMNPs at the RMNP:HEWL ratios of 0.025 and 1.250 at 
25 °C. As shown in figure 3a, the remaining activity of 
samples has been provided which shows that the functional 
stability of the enzyme has improved by the decline in the 
amount of RMNPs (RMNP:HEWL ratios of 0.025 (< CRT)) 
and vigorously reduced at RMNP:HEWL ratios of          
1.25 (> CRT) (Fig. 3a). 
      In biological fluids, proteins bind to  the  surface of  NPs 
 
Fig. 2. Study of  the structure-ordering  and  structure-breaking  effects of  RMNPs on HEWL after  treatment with 0.025  
            (< CRT) and 1.25 (> CRT) RMNP:HEWL ratios in the absence and presence of urea in phosphate-buffered saline  
            (PBS, 100 mM, pH = 7.4). (a) Effects of RMNP:HEWL ratios  on  changing  the  emission  spectra of tryptophan  
            intrinsic fluorescence of  HEWL  samples  as  revealed  by  fluorescence  spectroscopy, (b) Alterations in α-helix  
                 structure content of  HEWL  after  treatment with RMNPs  and (c) evaluation of the remaining HEWL activity in 
                 the presence of RMNPs. 
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to form a protein coating or corona which can critically 
affect the interaction of the NPs with its nearby environment 
including adjacent living systems [47]. The positive charge 
of the enzyme at neutral pH could be effectively adsorbed 
by the negatively charged RMNPs. Effective corona 
formation occurs in the far lower concentrations of RMNPs 
(<< CRT), and RMNPs are well saturated by proteins which 
in turn cooperatively brings about protein hydration and has 
a positive effect on the protein structure. Figure 3b 
illustrates the remaining activities of HEWL in three groups: 
in the absence of RMNPs at the beginning and             after 
64 h (controls); in the presence of RMNPs at                      
two representative RMNP:HEWL ratios including                     
0.025 (< CRT) or 1.25 (> CRT) after 64 hours with RMNPs 
separation; in the presence of RMNPs at two representative 
RMNP:HEWL ratios including 0.025 (< CRT) or                
1.25 (> CRT) after 64 h without RMNPs separation. It is 
obvious that the enzyme is preserved from loss of activity in 
the absence of RMNPs after 64 h. The remaining activity of 
the enzyme in the presence of RMNPs at RMNP:HEWL 
ratios of 0.025 (< CRT) or 1.25 (> CRT) without separation 
is improved and  declined  in  comparison  with  the  control  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
sample, respectively. Moreover, the remaining activity of 
the enzyme after 64 hours incubation in the presence of 
RMNPs at both RMNP:HEWL ratios of 0.025 (< CRT) and 
1.25 (> CRT), followed by RMNPs separation is effectively 
improved although the extent of improvement is reported to 
be higher for a representative ratio of <CRT than a 
representative ratio of > CRT. Upon separation of the 
RMNPs from the protein solution, due to the remaining 
single domain RMNPs, the ratio of RMNP:HEWL 
decreases significantly, which leads to a meaningful 
improvement in the structure-making effect (or 
kosmotropic-like) of RMNPs due to the falling 
RMNP:HEWL ratio to far less than the CRT (<< CRT), 
presumably to make an effective improvement in protein 
hydration. Additionally, these results can be suggestive that 
even high ratios are not detrimental to protein structure, and 
the negative effect of high ratios (>> CRT) is reversed upon 
their removal. 
      As lower final protein concentration in low 
concentrations of denaturant provides a greater efficiency of 
protein refolding, the unfolded urea treated protein is 
commonly diluted or dialyzed against  a  buffer  to  achieve  
 
Fig. 3. Concentration-dependent effect of RMNPs on the HEWL remaining activity at RMNP:HEWL ratios of 0.025  
           (< CRT)  and 1.250 (> CRT) in phosphate-buffered saline (PBS, 100 mM, pH = 7.4),  (a) during 64 h and (b) 
             at 64 h before and after separation of RMNPs. 
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protein refolding [48]. The efficiency of dilution of urea 
treated HEWL was investigated in the absence and presence 
of two representative RMNP:HEWL ratios of 0.025 and 
1.025 as < CRT and > CRT in PBS (100 mM, pH = 7.4), at 
room temperature upon examining the secondary structure, 
intrinsic fluorescence and activity analysis (Fig. 4). 
      Circular dichroism analysis (CD) was used to study the 
secondary structures of the HEWL as an indicative 
parameter of protein refolding [49]. As  depicted in  Fig. 4a, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
by performing dilution in the presence of RMNPs, the 
percentage of α-helix presents a sharp rise and β-strand 
conformations are more effectively decreased than in the 
absence of RMNPs. Accordingly, in comparison with the 
absence of RMNPs α-helix structure shows a further 7%    
and 2.6% increase in the presence of RMNPs at                           
0.025 (< CRT) and 1.25 (> CRT), respectively. Thus, the 
protein will have a more regular and stable structure. 
Moreover,   the  β-conformation   is   also  more  effectively 
 
Fig. 4. Secondary  and tertiary structure of HEWL in the absence and presence of RMNPs. Samples are native protein  
          (0.2 mg ml-1 HEWL in PBS, 100 mM, pH = 7.4), unfolded protein and protein treated with 30-fold diluted urea  
          in the absence and presence of RMNPs at RMNP:HEWL ratios of 0.025 (< CRT) and 1.25 (> CRT), evaluated  
             by (a) Far-UV CD spectra (b) Intrinsic fluorescence emission spectra, and (c) Remaining activity. 
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improved by diluting the HEWL in the presence of RMNPs 
rather than in their absence (Fig. 4a).  
      According to the fluorescence data provided in Fig. 4b, 
the achieved refolding efficiency by dilution was 62% in the 
absence of RMNPs which was increased to 64% at the 
RMNP:HEWL ratio of 0.025 (< CRT) and decreased to 
48.8% at the RMNP:HEWL ratio of 1.250 (> CRT). A 
higher increase in the efficiency of dilution for the refolding 
process is clearly seen at a low concentration of RMNPs, 
which is in good accordance with CD results. According to 
Fig. 4c, the remaining activity of the refolded HEWL shows 
an increase in activity in the presence of RMNPs in both 
concentrations: A remaining activity of 42.6% by dilution in 
the absence of RMNPs was increased to 56.4% in the 
presence of RMNPs at a ratio of 0.025 and 51.7% in the 
presence of RMNPs at a ratio of 1.25. Therefore, the 
ordering concentration of RMNPs in the kosmotropic-like 
ratios shows that the protein has more regular, stable 
conformation and also displays improved activity. In other 
words, at the RMNP:HEWL ratio of 0.025 (< CRT) the 
RMNPs can provide a considerable improvement in the 
refolding of the unfolded urea treated protein species using 
dilution.  
      As well as HEWL refolding using the dilution strategy, 
the influence of the RMNPs on the refolding of denatured 
HEWL in a dialysis system was also examined using 
intrinsic fluorescence and activity analysis (Fig. 5). The 
dialysis text was done overnight against PBS (100 mM, pH 
7.4) in the absence and presence of RMNPs at the 
RMNP:HEWL ratio of 0.025 (< CRT) with continuous 
stirring for 24 h at 4 °C in dialysis tubes (6-8 kDa cut-off). 
In Fig. 5a, the effect of the RMNP:HEWL ratio of 0.025 has 
been considered and the results of fluorescence 
spectroscopy are depicted. According to the fluorescence 
spectra presented in Fig. 5a, the HEWL denatured by urea 
illustrates a great rise in the fluorescence spectra which is a 
witness for refolding by performing dialysis. Moreover, 
improved refolding is reported in the presence of a 0.025 
ratio of RMNPs as a representative of the structure-ordering 
range of RMNP:HEWL ratios (< CRT). The effect of 
RMNPs on dialysis performance was also studied using 
HEWL remaining activity. A significant increase in the 
recovered HEWL activity is reported for dialysis of 
unfolded HEWL in the absence of RMNPs (†)  compared to 
 
 
the samples, which were dialyzed in the presence of RMNPs 
() from 56.5 to 63 percent (Fig. 5b). Accordingly, the 
RMNPs, at the RMNP:HEWL ratio of 0.025 (< CRT), 
effectively ameliorate the dialysis-based refolding of the 
unfolded urea-treated protein species. Thus, for increasing 
efficiency, using very small amounts of RMNPs (in the 
structure-ordering range) is recommended in the dilution 
and dialysis process. 
      Various RMNPs characteristics such as 
superparamagnetism, high surface area, large surface-to-
volume ratio, and easy separation under external magnetic 
fields, has attained great recognition for RMNPs, putting 
them in the spotlight for various applications in the 
biological industries. We endeavoured to study this new 
generation of MNPs modified by Arg as they influenced a 
model protein (HEWL) structure and function in the 
presence and absence of a denaturant (Urea), in a 
concentration-dependent fashion, since it is essential to 
comprehend the influence of RMNPs on HEWL storage, 
denaturation and refolding by dilution or dialysis. The 
interaction between RMNPs with HEWL was explored by a 
combination of structural and functional analysis. Although 
the mechanism of intercommunications between RMNPs 
and proteins has not been well understood and continues to 
be investigated, we discussed a protein hydration 
mechanism in the protein corona to support the structure 
ordering and disordering effects of RMNPs at 
RMNP:HEWL ratios lower or higher than the resulting 
CRT, respectively. A concentration ratio threshold (CRT) of 
RMNP:HEWL at 0.2962 was calculated and is suggested to 
be calculated independently prior to the utilization of NPs in 
any biological application, in order to assess the positive or 
negative effects of any kind of NPs.  
 
CONCLUSIONS 
 
      In this paper, Arg modified magnetic nanoparticles 
(RMNPs) were synthesized and their influence on the 
structure and function of the model protein hen egg white 
lysozyme (HEWL) (EC 3.2.1.1) is reported. We have 
described how RMNPs affect the structure and activity of 
HEWL in a concentration-dependent manner, both in the 
presence and absence of a denaturing agent, urea. RMNPs 
act as a double-edged sword which is  exhibited  by  either a  
  
 
Kashanian et al./Biomacromol. J., Vol. 5, No. 2, 83-94, December 2019. 
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
kosmotropic-like or chaotropic-like effect. When the ratio of 
RMNPs to HEWL is below the CRT (< CRT), the RMNPs 
assert a positive effect on the structure of the protein, and as 
stands to reason, at higher ratios than the CRT (> CRT) they 
break down the protein structure. Conversely, during the 
refolding of HEWL, unfolded due to the presence of urea, 
which is achieved through dilution or dialysis (urea 
removal), RMNPs show a curative effect in all 
RMNP:HEWL ratios. To conclude, based on our 
observations it is recommended to utilize RMNPs at ratios 
below the CRT whereupon HEWL structure and functions 
were preserved. Recovery of protein folding through 
dialysis or dilution subsequent to denaturation/solubilization 
by urea was also enhanced by RMNPs. These processes are 
extensively employed in biotechnology, nanomedicine and 
nanodiagnostics, hence emphasizing the use of RMNPs and 
studies to optimize their performance. 
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